User-Friendly OTC Dosage Forms Deliver Opportunity For Industry
Executive Summary
Hermes Pharma executive Thomas Hein recommends the OTC industry consider formulating APIs in user-friendly dosage forms, rather than in traditional tablets and capsules, to provide consumers with ease-of-swallowing and additional lifestyle convenience. Charts detail consumer preferences based on recent survey.
You may also be interested in...
Orally Dissolving Competition Lurks For Prevacid 24HR, Other OTC PPIs
While GSK Consumer Healthcare's latest ad campaign for Prevacid 24HR features "Lurker," a fireball character who educates consumers on the risk of recurrence of heartburn, oral disintegration of an active ingredient is the latest differentiator in the OTC PPI category.
Orally Dissolving Competition Lurks For Prevacid 24HR, Other OTC PPIs
While GSK Consumer Healthcare's latest ad campaign for Prevacid 24HR features "Lurker," a fireball character who educates consumers on the risk of recurrence of heartburn, oral disintegration of an active ingredient is the latest differentiator in the OTC PPI category.
OTC Innovation In An Age Of Pandemics – Q&A With Stada’s New R&D Head Stephen Makin
COVID-19 has shifted consumer health behaviour towards prevention and general wellbeing. However, finding out what consumers actually want and need is still the essence of good OTC innovation, according to Stada Arzneimittel's new vice president of consumer healthcare product development Steve Makin.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: